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Impact of concurrent Palliative Care
in lung cancer
Dr. Kavita Sharma (B2)
Program director
Advocate Aurora Health care Hospice and Palliative care fellowship
Milwaukee, WI

Objectives
• “Upstream” or early
Palliative care in Lung CA
• Models of delivery
• “Downstream” impacts:
business case for early
Palliative Care

Early Palliative Care for Patients with Metastatic
NSCLC N Engl J Med 2010; 363:733-742
• 2010, Jennifer Temel et al. published a seminal paper in NEJM on
early referral (within 8 wks. of diag) to subspecialty PC at MGH in
patients newly diagnosed with advanced non-small-cell lung cancer
• Objective: Does early PC for ambulatory NSCLC pts. improve QoL and
other factors (symptoms, mood, health care utilization)?
• Methods: 151 patients RCT simultaneous standard cancer care with
palliative care co-management from diagnosis (monthly visits) vs.
control of standard cancer care only

Early Palliative Care for Patients with Metastatic
NSCLC N Engl J Med 2010; 363:733-742
• Results at 30 months: 70% of subjects had died
• Improved QOL (FACT-L 98 vs. 91.5, p<0.03)
• Reduced depression (HADS 16% vs. 38%, p<0.01; PHQ-9 4% vs. 17%,
p< 0.04)
• 53% of subjects in PC arm had documented resuscitation preferences
compared to 28% in the usual care arm.
• Reduced ‘aggressiveness’ of care (33% vs. 54%, p<0.05) (chemo < 14d
before death, no hospice care, or hospice < 3 d before death)
• Fewer hospitalizations and ED visits amongst PC group
• Trend towards greater use of hospice in the PC group (69% vs 60%)
• Median survival in the PC group was 11.6 months from enrollment vs.
8.9 months in the usual care group (p<0.02)

Evolution of Palliative care in Lung cancer
The Washington Post
Study shows value of QOL in cancer
care (8/18/10)

National Public Radio, The Diane Rehm Show
New Studies in Palliative Care (8/24/20)

Boston Globe
Cancer strategy: Easing the burden
(8/19/10)

USA Today
Palliative care can help cancer patients live longer (8/18/10)

“Early outpatient palliative care in addition to usual oncology
care for metastatic non-small cell lung cancer improves
physical symptoms, depression, sense of well-being, and not
only doesn’t shorten life, but it may also prolong life”.

Explaining palliative care to oncology patients
• PC is a specialized area of medicine which provides an added layer to
the care of patients with cancer
• Help with symptom management, address psychosocial and spiritual
needs, improve quality of life
• Can be provided at any stage and along with curative treatments
• “Pilot” and “co-pilot” analogy

Who will benefit? Conceptual models for
integrating palliative care at cancer centers

J Palliat Med. 2012 Nov; 15(11): 1261–1269.

Criteria for palliative care referral
Delphi criteria

Modified Delphi criteria

Basic criteria

• Severe physical symptoms
• Severe emotional symptoms
• Patient request for hastened
death
• Spiritual or existential crisis
• Assistance with decision making
or advanced care planning
• Spinal cord compression
• Brain or leptomeningeal mets
• Delirium
• At patient request for referral
within 3 months of diagnosis of
CA with projected survival of 12
mo or less
• Progression after second line
therapy

•
•
•
•
•

• “surprise question”: If provider
would not be surprised if
patient were to die within a year
• Poor functional or performance
status
• Severe emotional or physical
symptoms

Severe physical symptoms
Severe emotional symptoms
Spinal cord compression
Brain or leptomeningeal mets
within 3 months of diagnosis of
CA with projected survival of 12
mo or less
• Progression after second line
therapy

Models of care delivery in PC

Case presentation
• 65 yr. old M with metastatic non small cell lung cancer in the setting
of advanced COPD for which he is dependent on home O2.
• He was diagnosed in 2/2019 when he was getting a CT scan for
chronic MAC infection.
• He was referred to Palliative care 07/2020 for pain management
related to his cancer.
• He lived alone, he has completed XRT, has had problems tolerating
systemic chemo, pneumonitis related to immunotherapy, and this is
on hold, did not have a health care directive.
• He was followed by Palliative care until he passed in 01/2022

Integrated Care Model
• Patients first undergo universal systematic assessments for physical
(disease related and chemo related), psychological, and spiritual concerns
(MDASI), and communication and decision-making needs by an
interprofessional team.
• Comprehensive management plan is developed: patient education, family
support, and various pharmacologic and nonpharmacologic interventions
tailored to the individual's needs.
• Specialized needs are addressed (e.g., pulmonary medicine for
thoracentesis, pain service for nerve blocks, endocrinology for diabetic
management).
• Comorbidities also are addressed.

Whole patient care
• Integrative and complementary therapies
• Counseling and support
• Educational resources
• Lifestyle change support: nutrition counseling, exercise and physical
activity consultations and tobacco cessation
• Ensures high standard of supportive care addressing complex
symptom concerns, minimizes duplication of services by appropriately
triaging, and optimizes personalized patient care interventions.

Making the business case for Palliative Care

The Costs of Waiting: Implications of the Timing of Palliative
Care Consultation among a Cohort of Decedents at a
Comprehensive Cancer Center J Palliat Med 2016 Jan;19(1):69-75.
Comparison of health care utilization and care quality for 297 patients
with cancer who died having received early versus late palliative care.
Early palliative care (> 90 days before death)
Hospitalizations

ICU stay
ED use last month of life

Late palliative care (< 90 days before death)
33%

66% (p < 0.01)

5%

20% (p < 0.01)

34%

54% (p = 0.04)

Direct costs of inpatient care last 6 mo of life

$19,067

$25,754 (p < 0.01)

Direct costs of outpatient care

$13,040

$11,549 (p = 0.85)

Venue of care

outpatient 84%

82% inpatient

Effect of early palliative care on health care costs
in patients with metastatic NSCLC 2012 ASCO Annual Meeting
• 151 patients with newly diagnosed met. NSCLC followed for 18 mos.
• 133 (88.1%) participants had died.
• Early PC group had mean cost savings of $2,282 per patient in total
health care expenditures during the final month of life.
• Lower costs for inpatient visits (mean saving per patient=$3,110) and
chemotherapy administration (mean saving per patient=$640).
• Outpatient clinic expenses were similar between groups.
• Costs for hospice services were greater for the early palliative care
group because of the longer lengths of stay in hospice care (mean
cost per patient=$1,125).

Upstream Palliative care for lung cancer…

